Diffuse alveolar hemorrhage following gemtuzumab ozogamicin.
Lin
T S
TS
Penza
S L
SL
Avalos
B R
BR
Lucarelli
M R
MR
Farag
S S
SS
Byrd
J C
JC
Copelan
E A
EA
D000617:Aminoglycosides / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000737:chemistry; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D000922:Immunotoxins / Q000009:adverse effects*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000473:pathology; D012074:Remission Induction; D033581:Stem Cell Transplantation; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000922:Immunotoxins; D013256:Steroids; D000079982:Gemtuzumab